95 related articles for article (PubMed ID: 2655543)
21. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
Huptas S; Geiss HC; Otto C; Parhofer KG
Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
[TBL] [Abstract][Full Text] [Related]
22. A randomized study comparing deflazacort and prednisone in heart transplant patients.
Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
[TBL] [Abstract][Full Text] [Related]
23. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
[TBL] [Abstract][Full Text] [Related]
24. Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects.
Pagano G; Lombardi A; Ferraris GM; Imbimbo B; Cavallo Perin P
Eur J Clin Pharmacol; 1982; 22(5):469-71. PubMed ID: 7117360
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of glucocorticoids on calcium absorption and bone mass.
Gennari C
Br J Rheumatol; 1993 May; 32 Suppl 2():11-4. PubMed ID: 8495275
[TBL] [Abstract][Full Text] [Related]
26. Anaphylaxis induced by intramuscular betamethasone disodium phosphate: reflections on a clinical case.
Ventura MT; Sanapo F; Calogiuri GF; Satriano F
Int J Immunopathol Pharmacol; 2007; 20(2):387-91. PubMed ID: 17624252
[TBL] [Abstract][Full Text] [Related]
27. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
Markham A; Bryson HM
Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
[TBL] [Abstract][Full Text] [Related]
28. Effects of prednisone and deflazacort on vertebral bone mass.
Gennari C; Imbimbo B
Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
[TBL] [Abstract][Full Text] [Related]
29. Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man.
Cavallo-Perin P; Bruno A; Ozzello A; Dall'Omo AM; Lombardi A; Cassader M; Imbimbo B; Pagano G
Eur J Clin Pharmacol; 1984; 26(3):357-62. PubMed ID: 6376142
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.
Lo Cascio V; Kanis JA; Beneton MN; Bertoldo F; Adami S; Poggi G; Zanolin ME
Calcif Tissue Int; 1995 Feb; 56(2):109-12. PubMed ID: 7736317
[TBL] [Abstract][Full Text] [Related]
31. Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man.
Bruno A; Carucci P; Cassader M; Cavallo-Perin P; Gruden G; Olivetti C; Pagano G
Eur J Clin Pharmacol; 1994; 46(5):411-5. PubMed ID: 7957534
[TBL] [Abstract][Full Text] [Related]
32. Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals.
Kauh E; Mixson L; Malice MP; Mesens S; Ramael S; Burke J; Reynders T; Van Dyck K; Beals C; Rosenberg E; Ruddy M
Eur J Endocrinol; 2012 Mar; 166(3):459-67. PubMed ID: 22180452
[TBL] [Abstract][Full Text] [Related]
33. Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients.
Ventura MT; Calogiuri GF; Matino MG; Dagnello M; Buquicchio R; Foti C; Di Corato R
Br J Dermatol; 2003 Jan; 148(1):139-41. PubMed ID: 12534608
[TBL] [Abstract][Full Text] [Related]
34. Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
Lund B; Egsmose C; Jørgensen S; Krogsgaard MR
Calcif Tissue Int; 1987 Dec; 41(6):316-20. PubMed ID: 3124940
[TBL] [Abstract][Full Text] [Related]
35. Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants.
Kim YS; Kim MS; Kim SI; Lim SK; Lee HY; Han DS; Park K
Transpl Int; 1997; 10(3):197-201. PubMed ID: 9163859
[TBL] [Abstract][Full Text] [Related]
36. An open comparison of the diabetogenic effect of deflazacort and prednisone at a dosage ratio of 1.5 mg:1 mg.
Sáez Barcelona JA; Carmona Martín M; Navarro López V; Blanch Sancho JJ; Puras Tellaeche A
Eur J Clin Pharmacol; 1999 Apr; 55(2):105-9. PubMed ID: 10335904
[TBL] [Abstract][Full Text] [Related]
37. Impact of cyclosporine and low-dose steroid therapy on insulin sensitivity and beta-cell function in patients with long-term liver grafts.
Konrad T; Markus B; Allers C; Vicini P; Toffolo G; Lakos C; Viehmann K; Hanisch E; Encke A; Cobelli C; Usadel KH
Transpl Int; 2001; 14(1):6-11. PubMed ID: 11263561
[TBL] [Abstract][Full Text] [Related]
38. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
[TBL] [Abstract][Full Text] [Related]
39. Beta 2-sympathomimetic activation as a cause of posthypoglycemic glucose intolerance.
Petersen KG; Kerp L
Horm Metab Res; 1988 Mar; 20(3):171-4. PubMed ID: 3290078
[TBL] [Abstract][Full Text] [Related]
40. Combined effect of terbutaline and betamethasone on glucose homeostasis in preterm labor.
Adam K; Ou CN; Cotton DB
Fetal Diagn Ther; 1993; 8(3):187-94. PubMed ID: 8240692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
